These include: Gallbladder problems: GLP-1 medications do have an increased risk for gallstones and gallbladder disease, especially when weight loss is rapid, McGowan says
They monitor how their body reacts to different foods, adjust their protein intake based on how full they feel, and identify which side effects indicate they need to adjust their approach
Phase 3 trials evaluating oral semaglutide in early-stage symptomatic Alzheimers disease did not meet their primary endpoints, tempering the earlier hypothesis that GLP-1s might offer direct neuroprotective benefits
But for patients experiencing sustained fatigue during the rapid weight loss phase of tirzepatide therapy
En los ltimos aos, se ha producido un cambio significativo en el tratamiento que, instaurado de forma precoz, ha permitido una mejora significativa de la calidad de vida y la supervivencia